Cell Reports (Feb 2020)

Multiplatform Molecular Profiling Reveals Epigenomic Intratumor Heterogeneity in Ependymoma

  • S. John Liu,
  • Stephen T. Magill,
  • Harish N. Vasudevan,
  • Stephanie Hilz,
  • Javier E. Villanueva-Meyer,
  • Sydney Lastella,
  • Vikas Daggubati,
  • Jordan Spatz,
  • Abrar Choudhury,
  • Brent A. Orr,
  • Benjamin Demaree,
  • Kyounghee Seo,
  • Sean P. Ferris,
  • Adam R. Abate,
  • Nancy Ann Oberheim Bush,
  • Andrew W. Bollen,
  • Michael W. McDermott,
  • Joseph F. Costello,
  • David R. Raleigh

Journal volume & issue
Vol. 30, no. 5
pp. 1300 – 1309.e5

Abstract

Read online

Summary: Ependymomas exist within distinct genetic subgroups, but the molecular diversity within individual ependymomas is unknown. We perform multiplatform molecular profiling of 6 spatially distinct samples from an ependymoma with C11orf95-RELA fusion. DNA methylation and RNA sequencing distinguish clusters of samples according to neuronal development gene expression programs that could also be delineated by differences in magnetic resonance blood perfusion. Exome sequencing and phylogenetic analysis reveal epigenomic intratumor heterogeneity and suggest that chromosomal structural alterations may precede accumulation of single-nucleotide variants during ependymoma tumorigenesis. In sum, these findings shed light on the oncogenesis and intratumor heterogeneity of ependymoma. : Tumor heterogeneity poses a barrier to cancer treatment. Liu et al. investigate radiographically distinct regions of an ependymoma tumor using transcriptomic, genetic, and epigenomic profiling and discover axes of gene expression programs that recapitulate normal brain development in addition to phylogenies that shed light on the tumorigenesis of ependymoma. Keywords: brain tumor, cancer, DNA methylation, C11orf95-RELA, ependymoma, epigenomics, exome sequencing, magnetic resonance imaging, RNA sequencing, SETD2